NCT07206849 2025-10-29Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)Nationwide Children's HospitalPhase 2 Not yet recruiting79 enrolled
NCT05760586 2024-08-12Expanded Access Program (EAP) for Tovorafenib (DAY101) in RAF-Altered, Relapsed or Refractory Low-Grade GliomaDay One Biopharmaceuticals, Inc.Approved for marketing